Tekmira Pharmaceuticals (TKMR) and European drug developer Bavarian Nordic (BAVA.CO) are receiving significant attention in early trading on Wednesday morning with announcements that their two distinct approaches to Ebola, a therapeutic and vaccine respectively, are advancing.

I wanted to claim a triumph, but it is hard to get excited about forcing the recognition of facts on a fellow-company in the information business.

The Euroland eleven who want to tax financial transactions are still grappling with definitions. While all of the European Union countries agree on taxing stock and bond sales they are in disarray over derivatives.

Not only are the tarnished Biotech, Electric Vehicle, and Internet darlings at the centre of the latest pullback much smaller as a percent of the NASDAQ market cap (<25%)

The misuse of fiscal policy over the post-war era is little short of a tragedy... governments were happy to embrace fiscal expansion in even the mildest downturns, but then found excuses not to unwind stimulus in the subsequent upswing.